Boston, MA -- (SBWIRE) -- 12/04/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Conatus Pharmaceuticals Inc (NASDAQ:CNAT), Janus Capital Group Inc (NYSE:JNS), eBay Inc (NASDAQ:EBAY), RXi Pharmaceuticals Corp (OTCMKTS:RXII).
Conatus Pharmaceuticals Inc (NASDAQ:CNAT), opened its shares at the price of $7.55for the day. Its closing price was $7.25 after gaining18.08% for the day. The company traded with the total volume of 1.24 million shares, while its average trading volume remained 28,349 shares.
Will CNAT Continue To Move Higher? Find Out Here
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States.
Janus Capital Group Inc (NYSE:JNS), percentage change plunged -1.49% to close at $10.57 with the total traded volume of 3.87 million shares, and average volume of 2.72 million. The 52 week range of the stock remained $7.68 - $11.04, while its day lowest price was $10.52 and it hit its day highest price at $10.76.
Will JNS Get Buyers Even After The Recent Rally? Find Out Here
Janus Capital Group, Inc. is a publicly owned asset management holding company with approximately $167.7 billion in assets under management.
eBay Inc (NASDAQ:EBAY), started its trading session with the price of $51.85 and closed at $51.93 by scoring 1.13%. EBAY’s stocks traded with total volume of 14.47 million shares, while the average trading volume remained 13.85 million shares. The beta of EBAY stands at 1.25. Day range of the stock was $51.27 -$52.22.
Will EBAY Continue To Move Higher? Find Out Here
eBay Inc. provides online platforms, tools, and services to help individuals and merchants in online and mobile commerce and payments in the United States and internationally.
RXi Pharmaceuticals Corp (OTCMKTS:RXII) ended its day with the loss of -0.97% and closed at the price of $3.07 after opening at $3.10. Stock traded during its last trading session with the total volume of 452,039 shares, as compared to its average volume of 49,889 shares.
Will RXII Get Buyers Even After The Recent Rally? Find Out Here
RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNAi platform
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)